In addition, TIMP1 was found downregulated in adenocarcinoma compared to BPH [33] and loss of TIMP1 correlated with biochemical recurrence in patients with localized PCa [34]. This evidence concerns the gene TIMP1 and benign prostatic hyperplasia.